Introduction
Skin soft tissue infections are a common type of disease in primary health-care institutions, including hyenas, gills, beehive inflammation and tan poison. The timely and rational application of antibiotics is essential for the control of infection and the rehabilitation of patients. As a first-generation antibiotic of the cystasy, the treatment of skin soft tissue infections is widely used in primary care. However, their unreasonable use may result in treatment failure, the generation of drug-resistant bacteria and an increase in the financial burden of patients and the adverse effects of drugs. It is therefore important to have an in-depth understanding of the characteristics and rational methods of use of beaming.
II. Pharmacological properties of aluminum cape
Capricorn, which is an antibiotic of β-neamide, acts by inhibiting the synthesis of bacterial cell walls, thus achieving microbicide. It has a high level of antibacterial activity for gland positive bacteria, such as golden streptococcus, streptococcus, which are common pathogens infected by skin soft tissue. As a result of oral exposure, aluminum is well absorbed and can be widely distributed in the body to achieve effective antibacterial concentrations in tissues and body fluids, especially in skin, soft tissues, which provide strong pharmaceutical dynamics support for the treatment of skin soft tissue infections.
III. Non-bacterial coverage of common pathogens infected with skin soft tissues and head acne ammonium
The range of pathogens infected with skin soft tissues is diverse, and the common gland positive bacteria include yellow fungus (including methoxysilin-yellow fungus, MRSA), septic streptococcus, skin-skinned grapes. Capricorn has a better antibacterial effect on most non-resistant gland positive bacteria, but it is less antibacterial for MRSA. In primary medical practice, capricorn is an effective treatment option for explicit or highly suspected skin soft tissue infections caused by sensitive gland positives, such as thorium, thorium and thorium. However, in the case of possible combinations of gelatin or MRSA infections, such as foot infections in diabetes patients, long-term hospitalization or skin soft tissue infections in patients with immunosuppressants, single-headed ammonium may not be effective in controlling the infection, and joint medications or replacement of other more appropriate antibiotics need to be considered.
IV. Clinical indications for the treatment of skin soft tissue infections in primary health-care facilities
1. Patients with mild to moderate simple skin soft tissue infections, such as limited larvae, pre-suppression, local red and edible fever is evident, but the whole body is less symptoms, has no fever or low heat, has a slight increase in the blood standard white cell count and has no apparent underlying disease or low immune function.
Condoxin, which is clearly caused by streptococcus, manifests itself in a clear line of red stains, oedema, accompanied by pain and heat, and the early and timely use of the aprimazine can effectively control the development of the condition and mitigate symptoms.
Patients with a wide range of infections, severe conditions associated with high heat, cold warfare, high overall poisoning symptoms, or with underlying diseases (e.g. diabetes mellitus, chronic kidney deficiencies, malignant neoplasms, etc.), low immune functions (e.g. AIDS, long-term use of glucose hormonal or immunosuppressants, etc.), as well as treatment with a mimonia 2 – 3 days, with no significant improvement or increase in the condition, should be referred to higher hospitals in a timely manner, with further examination, adjustment of treatment programmes, which may require treatment with higher levels of antibiotics or combinations.
V. METHODOLOGICAL USE OF HYDRAMMAT
In primary health-care institutions, oral administration is generally used. The common dose for adults was 0.25 – 0.5g per 6 hours; children were given a four-point dose at weight of 25 – 50 mg/kg per day. For patients with reduced kidney function, the dose should be adjusted to the acetic anhydride removal rate in order to avoid the accumulation of drugs in the body and increase the risk of adverse reactions. The course of treatment is generally 7 – 10 days, depending on the patient’s condition, symptoms and the type of pathogens, and it is not advisable to avoid the recurrence of the infection as a result of the premature withdrawal or to increase the likelihood of the drug being produced over a long period of time.
VI. DISAPPEARANCES AND NOTES IN THE HEADS OF STAFF
1. Negative effects
– The gastrointestinal reaction is more common, such as nausea, vomiting, diarrhoea, eating disorders, etc., generally light and self-resorting after withdrawal.
– A small number of patients may have allergies, in the form of rashes, itchings, muscular measles, etc., and in the case of serious cases, there can be a sensitization shock, so the patient ‘ s allergy history should be examined in detail before the drug is administered, and those who have allergies in the form of penicillin or headbactrin should be treated or banned.
– Hepato-renal function may also be impaired by the long-term or large-dose use of aluminum, e.g., ammonium enzyme, haemo-alkyl, etc., and the liver-renal function shall be monitored on a regular basis during the medication.
2. Attention
– The possibility of interaction between the co-use of the head ammonium and other drugs, such as propyl sulfuric sulfuric sulfuric sulfuric sulfuric sulfuric co-use, which increases the risk of adverse reactions; and the possible reaction of double-sulphuric gallons to the co-use of the ethanol, resulting in symptoms such as dizziness, headache, nausea, vomiting and so forth, so that alcohol consumption or the use of ethanol-containing drugs and food should be avoided during the use of the drug and within seven days after its cessation.
– Bacteria culture and drug sensitivity tests should be conducted before the use of head aroma to identify pathogens and their drug sensitivity and to guide clinically rational use. However, in primary health-care institutions, medically sensitive trials may not be carried out in a timely manner due to conditions, at which time treatment programmes should be adapted to the patient ‘ s clinical performance, the area of infection and the local experience of bacterial epidemiology, and to closely observe the patient ‘ s treatment response.
Conclusion
Capricorn has an important place in the treatment of skin soft tissue infections in primary health-care facilities, but must be used rationally. Basic health workers should be familiar with the pharmacological properties of capricorn, antibacterial spectroscopy, clinical application indications, usage, adverse reactions and care, and should be rigorous with drug indicators to avoid the abuse of antibiotics. In the course of drug use, changes in the patient ‘ s condition and adverse effects of the drug should be closely observed, and treatment programmes should be adapted in a timely manner to ensure that the patient has access to safe and effective treatment, while reducing the generation and spread of drug-resistant bacteria and contributing to the healthy development of primary health care.
